All Clinical Trials
Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.
Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI)
Study # NCT04957719 Date Opened: 08/14/2021 Closing Date: 08/31/2025 Sponsor: Idorsia Pharmaceuticals Ltd.
ThromboelAstogRaphy Guided Approach to Reduce Recurrent Events in ACS Patients Undergoing Catheter Based Intervention (TARGET-ACS)
Study # TARGET-ACS
Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
Study # FcGammaRIIa
A Single-Dose, Open-Label, Randomized, Multi-Center, 2-Treatment Crossover Study To Compare The Pharmacodynamics, Pharmacokinetics, Safety, And Tolerability Of Acetylsalicylic Acid Powder For Oral Inhalation With Non-Enteric-Coated Chewable Aspirin In Adu
Study # NCT05625347
Multidisciplinary Approach to Reduce Cardiovascular Health Disparities in the Baltimore Racial Minority Communities (M-BRACE Trial)
Study # M-BRACE Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Study # NCT02649426
A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy parallel-group, 2-arm, Phase 3 study to compare the efficacy of the oral FXIa inhibitor asundexian with apixaban for the prevention of stroke or systemic em
Study # SCFTR-02
A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT)
Study # VICTORION-2 PREVENT